AI Agent Performs Gene‑Therapy Surgery on Live Mouse
AI Agent Performs Gene‑Therapy Surgery on Live Mouse
A biotech startup demonstrated that an artificial‑intelligence agent can autonomously select a gene‑therapy protocol and successfully deliver it into a live mouse’s brain. The experiment, conducted in a controlled laboratory setting, marks a significant step toward automated, precision medicine research.
How the AI‑Driven Procedure Worked
The startup’s system was programmed with a library of gene‑therapy options. The AI evaluated the mouse’s genetic profile and selected a suitable vector. Using a robotic surgical platform, the agent performed a stereotactic injection directly into the targeted brain region, delivering the therapy with millimeter precision.
Implications for Biomedical Research
Automating the selection and delivery of gene therapies could accelerate preclinical studies, reduce human error, and lower costs. Researchers anticipate that such systems will enable high‑throughput testing of novel treatments in animal models.
Ethical and Safety Considerations
While the technology offers promise, it also raises questions about oversight, reproducibility, and animal welfare. Regulatory frameworks will need to adapt to ensure that AI‑guided procedures meet stringent safety standards.
Future Directions
Beyond mice, the same approach could be extended to larger animal models and, eventually, to human clinical trials—provided that rigorous validation and ethical review processes are in place.
Source: Wired
Watch and listen free on JASTORM – Follow radio and video broadcasts free in the JASTORM app with your free account.